SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

24 Jul 2025 Evaluate
A slight decline in the revenue of Rs. 0.64 millions was seen for the June 2025 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -0.08 millions as compared to Net Loss of Rs. -0.49 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -0.08% as compared to -0.49% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.64 0.00 0.00 0.64 0.00 0.00 1.88 0.36 422.22
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.08 -0.49 -83.67 -0.08 -0.49 -83.67 0.07 -1.46 -104.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.08 -0.49 -83.67 -0.08 -0.49 -83.67 0.07 -1.46 -104.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.08 -0.49 -83.67 -0.08 -0.49 -83.67 0.07 -1.46 -104.79
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.08 -0.49 -83.67 -0.08 -0.49 -83.67 0.05 -1.46 -103.42
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) -12.50 0.00 0.00 -12.50 0.00 0.00 3.72 -405.56 -100.92

Amerise Biosciences Share Price

0.68 0.01 (1.49%)
10-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×